Endpoint News: Post-Hoc: The next big pharma company will come from China

Endpoints News Executive Editor Drew Armstrong leads a conversation on China biopharma at the Financial Times summit, with Susan Winckler, CEO of the Reagan-Udall Foundation for the FDA, and Caitlin Frazer, executive director of the National Security Commission on emerging Biotechnology.